ROGINA GOSNELL: Open Payments
NPI 1518557198 · BROWNWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$255 in 15 payments from 9 companies in 2025. Trend: 2023 $144 · 2024 $303 · 2025 $255
Food & beverage: $255
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| ABBVIE INC. | 2 | $32 |
| Novo Nordisk Inc | 2 | $32 |
| Exact Sciences Corporation | 2 | $32 |
| Dexcom, Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Gilead Sciences, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
Products named: JARDIANCE, FARXIGA, QULIPTA, Ozempic, Cologuard Collection Kit, OFEV, Dexcom G6 Transmitter, Kerendia.
Industry payments across TX — which companies pay providers there.
